A study published in the medical journal European Urology reveals that robot-assisted surgery to treat prostate cancer is more common and significantly more successful in the United States than radical “open” surgery…
Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
27
Apr |
Robot Assisted Prostate Cancer Surgery Associated With Fever Complicated OutcomesCategory: Prostate / Prostate Cancer | Leave a Comment |
A study published in the medical journal European Urology reveals that robot-assisted surgery to treat prostate cancer is more common and significantly more successful in the United States than radical “open” surgery…
|
27
Apr |
The Aggressiveness Of Prostate Cancer Determined By New Diagnostic ToolCategory: Prostate / Prostate Cancer | Leave a Comment |
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It’s a serious problem and current diagnostic tests aren’t very specific…
|
26
Apr |
Robot-Assisted Prostate Cancer Surgery Leads To Fewer Complications, Better OutcomesCategory: Prostate / Prostate Cancer | Leave a Comment |
Robot-assisted surgery is now both more common and far more successful than radical “open” surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue of the medical journal European Urology…
|
17
Apr |
New Prostate Cancer Ultrasound Treatment Shows PromiseCategory: Prostate / Prostate Cancer | Leave a Comment |
A new experimental treatment for localized prostate cancer that uses high intensity focused ultrasound (HIFU) promises to be more effective and have fewer side effects than conventional treatments, according to a new study published early online in The Lancet Oncology on Tuesday…
|
17
Feb |
New Method Makes It Easier To Treat Prostate And Pancreatic CancerCategory: Prostate / Prostate Cancer | Leave a Comment |
Laser light in combination with certain drugs - known as photodynamic therapy - can destroy cancer tumours, but is today used mostly to cure skin cancer. The reason that internal tumours are not treated with the method is that the technology does not exist to check that the precise amount of light is administered…
|
14
Oct |
Quanterix PSA Test Found To Be A Reliable Predictor Of Prostate Cancer Recurrence Following SurgeryCategory: Prostate / Prostate Cancer | Leave a Comment |
Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, announced results from a clinical evaluation of its Prostate Specific Antigen (PSA) test, a fifth-generation digital immunoassay, demonstrating that the assay is a reliable predictor of five-year biochemical recurre…
|
7
Oct |
Drop Routine PSA Test For Prostate Cancer Says US PanelCategory: Prostate / Prostate Cancer | Leave a Comment |
Reports are coming in that an expert panel that advises the US government is set to recommend dropping routine screening for prostate cancer using the prostate specific antigen, or PSA, test…
|
7
Oct |
Researchers Develop A New Tool That Helps Identify Prostate Cancer Patients With The Highest Risk Of DeathCategory: Prostate / Prostate Cancer | Leave a Comment |
After a prostate cancer patient receives radiation treatment, his doctor carefully monitors the amount of prostate-specific antigen, or PSA, in his blood. An increase in PSA, called biochemical failure, is the first detectable sign of the cancer’s return to the prostate…
|
29
Sep |
Improved Collection Of Prostate Cancer Cells Promised By New UC ResearchCategory: Prostate / Prostate Cancer | Leave a Comment |
At the Oct. 2-6 microTAS 2011 conference, the premier international event for reporting research in microfluidics, nanotechnology and detection technologies for life science and chemistry, University of Cincinnati researchers will present a simple, low-cost, method for separating and safely collecting concentrated volumes of fragile prostate cancer cells…
|
21
Sep |
Identification Of Prostate Cancer Cells On The Horizon With Breakthrough Technology From UCSBCategory: Prostate / Prostate Cancer | Leave a Comment |
A team of researchers at UC Santa Barbara has developed a breakthrough technology that can be used to discriminate cancerous prostate cells in bodily fluids from those that are healthy. The findings are published this week in the Proceedings of the National Academy of Sciences…